CORT.US
id: 585
Corcept Therapeutics (CORT) $14M Securities Settlement
Late claims are being considered for compensation, subject to approval.
N.D. California
Court3:19-CV-01372
Case number08/02/2017
Class period Start01/31/2019
Class period End05/13/2024
Claim deadlineCorcept Therapeutics (CORT) agreed to settle $14 million with investors to end a securities class action lawsuit over concealing that it improperly paid doctors to promote its drug Korlym and inflated its revenue and sales using illicit sales practices through a related party.
Case Status
Accepting Late Claims
Alleged Offence
Misleading Statements,
Financial Misrepresentation,
Failure to Disclose,
Omissions
Suspected Party
Directors,
Management
Security Type
Stocks
Trade Direction
Long
Payout per Share
0.06
Filing date
03/14/2019
Lead Plaintiff Deadline
05/13/2019
Plaintiffs
Ferraro Family Foundation
Attorneys
Levi & Korsinsky, LLP (San Francisco, CA)
Defendants
Joseph K. Belanoff, Charles Robb, Sean Maduck
Judge
Hon. Lucy H. Koh
Administrator
A.B. Data Ltd
Settlement agreement date
2023-04-11
Court hearing date
06/06/2024
Exclusion deadline
05/13/2024
Objection deadline
05/13/2024
Trades matching type
FIFO
+$14,000,000
Cash Settlement AmountFrequently Asked Questions
Who is eligible for this settlement?
Do I have to sell securities to be eligible?
How much will my payment be?
How long does the payout process take?
What is 11thestate?